Multi-university study shows app can help students reduce symptoms, ease depression
Such delays lead to serious disparities in access to developmental therapy
In great need of in-person supports, developmentally disabled are overlooked in pandemic-related decisions, experts say
Fear of contracting or spreading COVID-19 might be increasing the severity of these symptoms, notes Dr. Cynthia Rogers.
In 2019, the FDA approved Spravato for patients with major depressive disorder who hadn’t responded to other treatments. Now, the agency is adding patients who are having suicidal thoughts or have recently attempted to harm themselves or take their own lives.